Piramal Pharma posts net loss of Rs 99 crore in Q1FY24 0 04.08.2023 15:04 Economictimes.indiatimes.com The contract research and manufacturing serivces (CDMO) revenues rose 17% YoY to Rs 898 crore led by order inflow momentum and strong execution in Q1FY24. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
